Zaditor (ketotifen)
/ Novartis
- LARVOL DELTA
Home
Next
Prev
1 to 12
Of
12
Go to page
1
March 28, 2025
Treatment of allergic rhinitis and allergic conjunctivitis.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Allergic Rhinitis • Allergy • Conjunctivitis • Immunology • Inflammation • Ocular Infections • Ocular Inflammation • Ophthalmology
June 24, 2024
KICC COVID-19: Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19
(clinicaltrials.gov)
- P3 | N=150 | Completed | Sponsor: Sen-Jam Pharmaceutical | Recruiting ➔ Completed | Trial completion date: Dec 2024 ➔ Jun 2024
Trial completion • Trial completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
July 12, 2023
KICC COVID-19: Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19
(clinicaltrials.gov)
- P3 | N=150 | Recruiting | Sponsor: Sen-Jam Pharmaceutical | Trial completion date: Dec 2022 ➔ Dec 2024 | Trial primary completion date: Sep 2022 ➔ Sep 2024
Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
May 12, 2022
In brief: OTC alcaftadine (Lastacaft Once Daily Relief) for allergic conjunctivitis.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Conjunctivitis • Ocular Infections • Ocular Inflammation • Ophthalmology
May 09, 2022
KICC COVID-19: Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19
(clinicaltrials.gov)
- P3 | N=150 | Recruiting | Sponsor: Sen-Jam Pharmaceutical | Not yet recruiting ➔ Recruiting | Initiation date: Dec 2021 ➔ May 2022
Enrollment open • Trial initiation date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
April 19, 2022
A drug-eluting contact lens for allergic conjunctivitis.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Conjunctivitis • Ocular Infections • Ocular Inflammation • Ophthalmology
November 26, 2021
KICC COVID-19: Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19
(clinicaltrials.gov)
- P3; N=150; Not yet recruiting; Sponsor: Sen-Jam Pharmaceutical; Phase classification: P2 ➔ P3; Initiation date: Sep 2021 ➔ Dec 2021
Clinical • Phase classification • Trial initiation date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
August 16, 2021
KICC COVID-19: Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19
(clinicaltrials.gov)
- P2; N=150; Not yet recruiting; Sponsor: Sen-Jam Pharmaceutical
New P2 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
April 14, 2021
Drugs for allergic rhinitis and allergic conjunctivitis.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Allergic Rhinitis • Allergy • Conjunctivitis • Immunology • Ocular Infections • Ocular Inflammation • Ophthalmology
March 12, 2012
Novel Use of (Oral) Ketotifen for the Treatment of Fibromyalgia: A Pilot Study
(clinicaltrials.gov)
- P3; N=46; Active, not recruiting; Sponsor: Indiana University
Clinical • New P3 trial
October 10, 2012
Novel Use of (Oral) Ketotifen for the Treatment of Fibromyalgia: A Pilot Study
(clinicaltrials.gov)
- P3; N=46; Active, not recruiting; Sponsor: Indiana University; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed
June 07, 2019
OTC drugs for seasonal allergies.
(PubMed, Med Lett Drugs Ther)
- No abstract available.
Journal
1 to 12
Of
12
Go to page
1